Engaging in physical and mentally stimulating activities has long been associated with a lower risk of mild cognitive impairment and dementia. Yet the precise biological pathways behind these links remain unclear, especially in humans. The new study addresses this gap by focusing on three core Alzheimer's neuroimaging biomarkers: amyloid deposition measured with Pittsburgh compound B (PiB-PET), tau accumulation measured with flortaucipir tau-PET, and regional brain glucose metabolism measured with FDG-PET. These biomarkers reflect distinct aspects of Alzheimer's pathophysiology - amyloid and tau as hallmark proteins, and glucose metabolism as an indicator of synaptic function.
The research team analyzed data from 1,181 adults aged 50 and older, all either cognitively unimpaired or diagnosed with mild cognitive impairment at baseline. Participants completed detailed questionnaires describing the frequency and intensity of physical activities - ranging from light household tasks to vigorous exercise - as well as the range of cognitive activities they regularly engaged in, including reading, game-playing, music, crafts, and social or group activities. These self-reported measures were converted into standardized composite scores for total physical activity, moderate-to-vigorous physical activity (MVPA), and total cognitive activity.
Participants also underwent PET imaging at baseline and at one or more follow-up visits over an average of one to three years, depending on the biomarker. As expected, amyloid and tau levels increased over time, while glucose metabolism declined, reflecting typical age-related and Alzheimer's-related trajectories. The study's central question was whether baseline lifestyle activity levels predicted how quickly these changes unfolded.
The strongest associations emerged for FDG-PET, the measure of brain glucose metabolism. Higher total physical activity and higher MVPA both predicted a slightly slower decline in glucose metabolism over time. This finding aligns with prior suggestions that physically active individuals may experience reduced synaptic dysfunction, even if the underlying mechanisms remain difficult to isolate. The estimated effects were small: for example, participants one standard deviation above the mean in physical activity showed an annual FDG-PET decline that was modestly less pronounced than those at average activity levels.
Cognitive activity showed a broader but similarly modest pattern of associations. Individuals with higher engagement in cognitively stimulating activities demonstrated both a slower decline in glucose metabolism and a less pronounced increase in amyloid deposition as measured by PiB-PET. This association with amyloid, although statistically significant, represented a very small effect - equivalent to a delay of roughly one month in reaching the standard amyloid-positivity threshold for an average participant. When projected across individuals with higher or lower initial amyloid levels, the cumulative impact could extend the amyloid-negative period by up to a year, though the clinical significance of such a delay is uncertain.
By contrast, neither physical nor cognitive activity showed any meaningful association with tau-PET trajectories. This absence aligns with several human studies but diverges from some cross-sectional evidence in smaller samples. The authors note that tau accumulation may respond differently to lifestyle factors, or that the relatively short follow-up period limited their ability to detect changes. Tau pathology also tends to accelerate at later stages of disease progression, meaning midlife activity patterns - or longer observational windows - might be more informative in future research.
The study also tested whether baseline cognitive status - cognitively unimpaired versus mild cognitive impairment - altered the relationship between activities and biomarker changes. No modifying effects emerged, suggesting that the observed patterns were consistent across both groups. This strengthens the interpretation that lifestyle activity and biomarker trajectories are linked in a similar manner across early cognitive aging.
While the findings are encouraging, the authors emphasize their modest scale and observational nature. Because activity levels were self-reported, recall bias is inevitable. More importantly, reverse causality remains a plausible explanation: individuals with healthier brains may be more active, rather than activity directly slowing disease processes. A single year of activity assessment may also be insufficient to reflect the cumulative influence of lifestyle habits across decades - particularly given that Alzheimer's preclinical changes can begin long before symptoms appear. The sample was also predominantly White and highly educated, limiting generalizability.
Despite these limitations, the study contributes valuable longitudinal evidence to a field often dominated by cross-sectional designs or small samples. It also complements ongoing intervention trials investigating whether structured physical or multi-domain lifestyle programs can alter biomarkers or cognitive outcomes. As those trials continue to report results, observational work of this scale helps refine expectations about what lifestyle changes can realistically influence and over what time frame.
From the perspective of Seven Reflections' Dimensional Systems Architecture (DSA) framework, the findings underscore a key principle: systems maintain stability when multiple functional fields stay active and integrated. Physical and cognitive activities may not dramatically shift biological markers, but they appear to support a more coherent metabolic field within the brain - reflected in the slower decline of glucose utilization. In DSA terms, these activities help maintain structural efficiency in the cognitive system by keeping energy flow, engagement, and pattern-formation circuits active. The small effect sizes observed in the study are consistent with a system that adapts gradually, where lifestyle inputs act more as continuous stabilizers than direct causal drivers of neurodegeneration.
DSA also emphasizes the importance of system-level interactions over isolated mechanisms. The distinction between amyloid, tau, and glucose metabolism is useful scientifically, yet human cognition emerges from the coordination of these processes rather than their individual trajectories. The study's subtle signals - protective associations seen mostly in glucose metabolism and, to a lesser degree, amyloid accumulation - suggest that lifestyle factors may first influence broad metabolic coherence before impacting more rigid protein-pathology pathways. This reflects the DSA view that system-wide energetic stability precedes structural change.
Overall, the Mayo Clinic findings highlight the nuanced relationship between lifestyle activity and brain health. While physical and cognitive engagement do not halt Alzheimer's pathology, they appear to support a more resilient cognitive-energetic field - an idea that resonates with both biological evidence and the structural logic emphasized by DSA.
